Genetic polymorphism of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) in patients with bullous pemphigoid in a Polish population
By:
References
- Mahid S.S., Colliver D.W., Crawford N.P., Martini B.D., Doll M.A., Hein D.W., Cobbs G.A., Petras R.E., Galandiuk S.: Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma. BMC Med. Genet., 2007; 8: 28
- Rychlik-Sych M., Skrętkowicz J.: Metabolizm leków. Farm. Pol., 2008; 64: 51–60
- Sheehan D., Meade G., Foley V.M., Dowd C.A.: Structure, function and evolution of glutatione transferases: Implications for classification of non-mammalian members of an ancient enzyme super-family. Biochem. J., 2001; 360: 1–16
- Gallagher E.P., Gardner J.L., Barber D.S.: Several glutathione S-transferase isozymes that protect against injury are expressed in human liver mitochondria. Biochem. Pharmacol., 2006; 71: 1,619–1,628
- Marchewka Z., Piwowar A., Ruzik S., Długosz A.: Glutathione S-transferases class Pi and Mi and their significance in oncology. Postępy Hig. Med. Dośw., 2017; 71: 541–550
- Kerb R., Brockmöller J., Reum T., Roots I.: Deficiency of glutathi-one S-transferases T1 and M1 as heritable factors of increased cutaneous UV sensitivity. J. Invest. Dermatol., 1997; 108: 229–232
- Strange R.C., Spiteri M.A., Ramachandran S., Fryer A.A.: Glutathione-S-transferase family of enzymes. Mutat. Res., 2001; 482: 21–26
- Lo H.W., Ali-Osman F.: Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr. Opin. Pharmacol., 2007; 7: 367–374
- Matic M.G., Coric V.M., Savic-Radojevic A.R., Bulat P.V., Pljesa-Ercegovac M.S., Dragicevic D.P., Djukic T.I., Simic T.P., Pekmezovic T.D.: Does occupational exposure to solvents and pesticides in association with glutathione S-transferase A1, M1, P1, and T1 polymorphisms increase the risk of bladder cancer? The Belgrade Case-Control Study. PLoS One, 2014; 9: e99448
- Bolt H.M., Thier R.: Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr. Drug Metab., 2006; 7: 613-628
- Board P.G., Menon D.: Glutathione transferases, regulators of cellular metabolism and physiology. Biochim. Biophys. Acta, 2013; 1830: 3,267–3,288
- Fryer A.A., Bianco A., Hepple M., Jones P.W., Strange R.C., Spiteri M.A.: Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am. J. Respir. Crit. Care Med., 2000; 161: 1,437–1,442
- Dumitrescu R.G., Cotarla I.: Understanding breast cancer risk— where do we stand in 2005? J. Cell. Mol. Med., 2005; 9: 208–221
- Jardim B.V., Moschetta M.G., Gelaleti G.B., Leonel C., Regiani V.R., de Santi Neto D., Bordin-Junior N.A., Perea S.A., Zuccari D.A.: Glutathione transferase pi (GSTpi) expression in breast cancer: An immunohistochemical and molecular study. Acta Histochem., 2012; 114: 510–517
- Strange R.C., Fryer A.A.: The glutathione S-transferases: Influence of polymorphism on cancer susceptibility. IARC Sci. Publ., 1999; 148: 231–249
- Habdous M., Siest G., Herbeth B., Vincent-Viry M., Visvikis S.: Glutathione S-transferases genetic polymorphisms and human diseases: Overview of epidemiological studies. Ann. Biol. Clin., 2004; 62: 15–24
- Pljesa-Ercegovac M., Savic-Radojevic A., Dragicevic D., Mimic-Oka J., Matic M., Sasic T., Pekmezovic T., Vuksanovic A., Simic T.: Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways. Urol. Oncol., 2011; 29: 70–77
- Lo Schiavo A., Ruocco E., Brancaccio G., Caccavale S., Ruocco V., Wolf R.: Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies. Clin. Dermatol., 2013; 31: 391–399
- Schmidt E., Reimer S., Kruse N., Jainta S., Bröcker E.B., Marinkovich M.P., Giudice G.J., Zillikens D.: Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J. Invest. Dermatol., 2000; 115: 842–848
- Waszczykowska E., Wysoczańska K., Żebrowska A.: The role of cytokines in the pathogenesis of autoimmune bullous skin disease. Alerg. Astma Immun., 2004; 9: 179–186
- Zakka L.R., Reche P., Ahmed A.R.: Role of MHC Class II genes in the pathogenesis of pemphigoid. Autoimmun. Rev., 2011; 11: 40–47
- de Graauw E., Sitaru C., Horn M.P., Borradori L., Yousefi S., Simon D., Simon H.U.: Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid. Allergy, 2018; 73: 1,119–1,130
- Shah A.A., Sinha A.A.: Oxidative stress and autoimmune skin disease. Eur. J. Dermatol., 2013; 23: 5–13
- Otten J.V., Hashimoto T., Hertl M., Payne A.S., Sitaru C.: Molecular diagnosis in autoimmune skin blistering conditions. Curr. Mol. Med., 2014; 14: 69–95
- Gorukmez O., Yakut T., Gorukmez O., Sag S.O., Topak A., Sahinturk S., Kanat O.: Glutathione S-transferase T1, M1 and P1 genetic polymorphisms and susceptibility to colorectal cancer in Turkey. Asian Pac. J. Cancer Prev., 2016; 17: 3,855–3,859
- Abbas A., Delvinquiere K., Lechevrel M., Lebailly P., Gauduchon P., Launoy G., Sichel F.: GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: Different pattern of squamous cell carcinoma and adenocarcinoma. World J. Gastroenterol., 2004; 10: 3,389–3,393
- Kulbacka J., Saczko J., Chwiłkowska A.: Oxidative stress in cells damage processes. Pol. Merk. Lekarski, 2009; 27: 44–47
- Sheu S.S., Nauduri D., Anders M.W.: Targeting antioxidants to mitochondria: A new therapeutic direction. Biochim. Biophys. Acta, 2006; 1,762: 256–265
- Tie D., Da X., Natsuga K., Yamada N., Yamamoto O., Morita E.: Bullous pemphigoid IgG induces cell dysfunction and enhances the motility of epidermal keratinocytes via Rac1/proteasome activation. Front. Immunol., 2019; 10: 200
- Sarniak A., Lipińska J., Tytman K., Lipińska S.: Endogenous mechanisms of reactive oxygen species (ROS) generation. Postępy Hig. Med. Dośw., 2016; 70: 1,150–1,165
- Bratic A., Larsson N.G.: The role of mitochondria in aging. J. Clin. Invest., 2013; 123: 951–957
- Wang C.H., Wu S.B., Wu Y.T., Wei Y.H.: Oxidative stress response elicited by mitochondrial dysfunction: Implication in the pathophysiology of aging. Exp. Biol. Med., 2013; 238: 450–460
- Maeshima E., Liang X.M., Goda M., Otani H., Mune M.: The efficacy of vitamin E against oxidative damage and autoantibody production in systemic lupus erythematosus: A preliminary study. Clin. Rheumatol., 2007; 26: 401–404
- Shah A.A., Dey-Rao R., Seiffert-Sinha K., Sinha A.A.: Increased oxidative stress in pemphigus vulgaris is related to disease activity and HLA-association. Autoimmunity, 2016; 49: 248–257
- Casciola-Rosen L., Rosen A.: Ultraviolet light-induced keratinocyte apoptosis: A potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus, 1997; 6: 175–180
- Salimi S., Nakhaee A., Jafari M., Jahantigh D., Sandooghi M., Zakeri Z., Shahrakipour M., Naghavi A., Farajian-Mashhadi F.: Combination effect of GSTM1, GSTT1 and GSTP1 polymorphisms and risk of systemic lupus erythematosus. Iran. J. Public Health, 2015; 44: 814–821
- Glesse N., Rohr P., Monticielo O.A., Rech T.F., Brenol J.C., Xavier R.M., Kvitko K., Chies J.A.: Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients. Mol. Biol. Rep., 2014; 41: 6,167–6,179
- Fraser P.A., Ding W.Z., Mohseni M., Treadwell E.L., Dooley M.A., St Clair E.W., Gilkeson G.S., Cooper G.S.: Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: A possible gene-environmental interaction for autoimmunity. J. Rheumatol., 2003; 30: 276–282
- Karlson E.W., Watts J., Signorovitch J., Bonetti M., Wright E., Cooper G.S., McAlindon T.E., Costenbader K.H., Massarotti E.M., Fitzgerald L.M., et al.: Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: Results From the Roxbury Lupus Project. Arthritis Rheum., 2007; 56: 244–254
- Tew M.B., Reveille J.D., Arnett F.C., Friedman A.W., McNearney T., Fischbach M., Ahn C., Tan F.K.: Glutathione S-transferase genotypes in systemic sclerosis and their association with clinical manifestations in early disease. Genes Immun., 2001; 2: 236–238
- Palmer C.N., Young V., Ho M., Doney A., Belch J.J.: Association of common variation in glutathione S-transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis. Arthritis Rheum., 2003; 48: 854–855
DOI: https://doi.org/10.2478/ahem-2021-0018 | Journal eISSN: 1732-2693
Language: English
Page range: 896 - 903
Submitted on: Sep 2, 2020
Accepted on: May 25, 2021
Published on: Dec 30, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2021 Mariola Rychlik-Sych, Małgorzata Barańska, Michał Dudarewicz, Jadwiga Skrętkowicz, Agnieszka Żebrowska, Jacek Owczarek, Anna Wiktorowska-Owczarek, Daria Orszulak-Michalak, Elżbieta Waszczykowska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.